GeneNews' Q3 Revenues Fall 74 Percent; PGx, MDx Services Launched | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews' third-quarter revenues plummeted 74 percent year over year, the Canadian developer of blood-based biomarker tests reported after the close of the market on Thursday.

In a document filed with Canadian regulators, the company said that revenues in the quarter totaled C$43,999 (US$44,241), down from C$166,515 a year ago as non-refundable licensing revenues dropped to zero from C$162,619 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.